Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A

Neuromuscular Disorders

Volumn 18, Issue 8, 2008, Pages 610-618

  Chung, K W ^a   Suh, B C ^b   Shy, M E ^c   Cho, S Y ^d   Yoo, J H ^d   Park, S W ^a   Moon, H ^b   Park, K D ^d   Choi, K G ^d   Kim, S ^e   Kim, S B ^f   Shim, D S ^g   Kim, S M ^g   Sunwoo, I N ^g   Choi, B O ^d  

^a Kongju National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ewha Womans University School of Medicine   (South Korea)

^e Hanyang University College of Medicine   (South Korea)

^f Kyung Hee University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

Author keywords

Charcot Marie Tooth disease; Fatty infiltration; Magnetic resonance imaging; Mitofusin 2; PMP22

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGE OF ONSET; AGED; ATROPHY; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CHILD, PRESCHOOL; DNA; EDEMA; FEMALE; FOOT; GENE DUPLICATION; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUTATION;

EID: 48549088834     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.05.012     Document Type: Article

References (36)

1. Harding A.E., and Thomas P.K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103 (1980) 259-280
2. Nicholson G.A. Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies. Neurology 41 (1991) 547-552
3. Shy M.E., Garbern J.Y., and Kamholz J. Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 1 (2002) 110-118
4. Züchner S., Mersiyanova I.V., Muglia M., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36 (2004) 449-451
5. Szigeti K., Garcia C.A., and Lupski J.R. Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management. Genet Med 8 (2006) 86-92
6. Verhoeven K., Claeys K.G., Züchner S., et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129 (2006) 2093-2102
7. Lupski J.R., de Oca-Luna R.M., Slaugenhaupt S., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66 (1991) 219-232
8. Krajewski K.M., Lewis R.A., Fuerst D.R., et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123 (2000) 1516-1527
9. Rojo M., Legros F., Chateau D., and Lombes A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci 115 (2002) 1663-1674
10. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., and Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160 (2003) 189-200
11. Koshiba T., Detmer S.A., Kaiser J.T., Chen H., McCaffery J.M., and Chan D.C. Structural basis of mitochondrial tethering by mitofusin complexes. Science 305 (2004) 858-862
12. Baloh R.H., Schmidt R.E., Pestronk A., and Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 27 (2007) 422-430
13. Züchner S., De Jonghe P., Jordanova A., et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 59 (2006) 276-281
14. Thomas P.K., Marques Jr. W., Davis M.B., et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120 (1997) 465-478
15. Chung K.W., Kim S.B., Park K.D., et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129 (2006) 2103-2118
16. Fleckenstein J.L., Watumull D., Conner K.E., et al. Denervated human skeletal muscle: MR imaging evaluation. Radiology 187 (1993) 213-218
17. May D.A., Disler D.G., Jones E.A., Balkissoon A.A., and Manaster B.J. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 20 (2000) S295-S315
18. Farber J.M., and Buckwalter K.A. MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin North Am 40 (2002) 1013-1031
19. Stilwell G., Kilcoyne R.F., and Sherman J.L. Patterns of muscle atrophy in the lower limbs in patients with Charcot-Marie-Tooth disease as measured by magnetic resonance imaging. J Foot Ankle Surg 34 (1995) 583-586
20. Gallardo E., Garcia A., Combarros O., and Berciano J. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129 (2006) 426-437
21. Price A.E., Maisel R., and Drennan J.C. Computed tomographic analysis of pes cavus. J Pediatr Orthop 13 (1993) 646-653
22. Bienfait H.M., Verhamme C., Schaik I.N., et al. Comparison of CMT1A and CMT2: similarities and differences. J Neurol 253 (2006) 1572-1580
23. Choi B.O., Kim J., Lee K.L., Yu J.S., Hwang J.H., and Chung K.W. Rapid diagnosis of CMT1A duplications and HNPP deletions by multiplex microsatellite PCR. Mol Cells 23 (2007) 39-48
24. Birouk N., Gouider R., Le Guern E., et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120 (1997) 813-823
25. Shy M.E., Blake J., Krajewski K., et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64 (2005) 1209-1214
26. Goutallier D., Postel J.M., Bernageau J., Lavau L., and Voisin M.C. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 304 (1994) 78-83
27. Davies MS. Foot and ankle. In: Standring S, editor. Gray's anatomy. London: Elsevier Churchill Livingston; 2005. p. 1507-45.
28. Harding A.E. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 118 (1995) 809-818
29. Dahmane R., Djordjevic S., Simunic B., and Valencic V. Spatial fiber type distribution in normal human muscle Histochemical and tensiomyographical evaluation. J Biomech 38 (2005) 2451-2459
30. Rubinstein N.A., and Kelly A.M. Myogenic and neurogenic contributions to the development of fast and slow twitch muscles in rat. Dev Biol 62 (1978) 473-485
31. Kugelberg E. Adaptive transformation of rat soleus motor units during growth. J Neurol Sci 27 (1976) 269-289
32. Rubinstein N.A., and Kelly A.M. Development of muscle fiber specialization in the rat hindlimb. J Cell Biol 90 (1981) 128-144
33. Buchthal F., and Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 100 (1977) 41-66
34. Bienfait H.M., Baas F., Koelman J.H., et al. Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology 68 (2007) 1658-1667
35. Berciano J., García A., and Combarros O. Initial semiology in children with Charcot-Marie-Tooth disease. Muscle Nerve 27 (2003) 34-39
36. García A., Combarros O., Calleja J., and Berciano J. Charcot-Marie-Tooth disease type 1A with 17p duplication in early infancy and childhood. A longitudinal clinical and electrophysiological study. Neurology 50 (1998) 1061-1067